Dr. Moshe Neuman, Ph.D. serves as the President & CEO of Bio-Medical Research Design Ltd. (B.R.D) founded in 1998. He bears over eighteen years of experience in the fields of pharmaceutical, medical device research & development, and regulatory compliance. His regulatory expertise includes both FDA, and EU/ICH regulations.
He obtained his Ph.D. in physiology and pharmacology from the Tel – Aviv University Medical School. As an academic research associate of the physiology and pharmacology department he gained a wide research background mainly in cardiovascular pharmacology (Development of new Antiarrhythmic, anti-hypertensive, and inotropic agents therapy).
Before that, at the Biological Research Institute, Nes Ziona, Israel and following his Ph.D. at many stages of his career he has been involved and participated as a study director, as well as a consultant in multiple pre-clinical efficacy research studies, PK and ADME studies in addition to toxicology studies and biocompatibility testing, using different animal models.
Following the establishment of the Clinical Research Unit at the Neufeld Cardiac Research Institute, Sheba Medical Center, he spent 3 years as the director of diverse medical and research programs in cardiovascular, respiratory, diabetics and oncology fields expanding his pre-clinical experience into the clinical trials industry - as a Clinical Research Associate and Clinical study coordinator for global pharmaceutical companies.
During his post doctorial fellowship at CPI, Minneapolis, USA, he received experience in the medical device field, as well as with the FDA QSR requirements being involved in the R&D, technology transfer and the clinical testing of the new Implantable Defibrillator generation.
At present he is a member of the Medicinal Chemistry faculty of the Tel Aviv University, where he lectures the Biotechnology enterprising course.